Search

Your search keyword '"Candini Olivia"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Candini Olivia" Remove constraint Author: "Candini Olivia"
125 results on '"Candini Olivia"'

Search Results

1. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma

Catalog

Books, media, physical & digital resources

3. Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility

4. Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma

5. Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia

6. GD2 CAR T cells against human glioblastoma

11. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer

12. Morphologic, phenotypic, and genotypic similarities between primary tumors and corresponding 3D cultures grown in a repeatable system

13. MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential

14. Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance

19. Additional file 1 of Microfragmented adipose tissue is associated with improved ex vivo performance linked to HOXB7 and b-FGF expression

20. Additional file 2 of Microfragmented adipose tissue is associated with improved ex vivo performance linked to HOXB7 and b-FGF expression

29. MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

30. Additional file 4: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

31. Additional file 1: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

32. Additional file 7: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

33. Additional file 6: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

34. Additional file 5: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

35. Additional file 2: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

36. Additional file 3: of Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

37. Resistance to neoplastic transformation ofex-vivoexpanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress

38. Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?

41. Age related miRNA signature in mesenchymal progenitors reveals key players in cellular performance and fate

42. Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis

44. Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility.

45. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells

46. Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility

47. Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients

48. Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies.

49. Mesenchymal Progenitors Aging Highlights a mi R-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis.